MRS links fibromyalgia pain to changes in brain molecule
A new study from the University of Michigan featuring proton MR spectroscopy has found a key linkage between the widespread muscle pain, tenderness, and fatigue associated with fibromyalgia and brain glutamate. Findings could lead to new drugs to treat the condition, researchers said.
A new study from the University of Michigan featuring proton MR spectroscopy has found a key linkage between the widespread muscle pain, tenderness, and fatigue associated with fibromyalgia and brain glutamate. Findings could lead to new drugs to treat the condition, researchers said.
Dr. Daniel J. Clauw, director of the UM Chronic Pain and Fatigue Research Center, and colleagues evaluated 21 patients with fibromyalgia and 27 healthy controls who underwent H1-MRS once before and once following a four-week course of acupuncture or "sham" acupuncture to reduce pain. They found that patients with greater reductions in pain showed greater reductions in glutamate in the insular cortex. Their findings appear in Arthritis and Rheumatism.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.
Study Says MRI Offers Most Cost-Effective Imaging for Dizziness Presentations in the ER
November 10th 2023Noting that initial imaging sensitivity is a key factor in cost-effectiveness for patients who do not require acute treatment for dizziness, researchers found that specialized MRI (including multiplanar high-resolution DWI) provided the most benefit in a comparative trial of neuroimaging modalities.
